Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000712392 | SCV000531255 | benign | not provided | 2018-08-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086034 | SCV000640764 | benign | Nemaline myopathy 2 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000712392 | SCV000842870 | benign | not provided | 2018-06-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000712392 | SCV004011206 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | NEB: BP4, BP7, BS1, BS2 |
Genetic Services Laboratory, |
RCV000117752 | SCV000152007 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Natera, |
RCV001086034 | SCV002077778 | benign | Nemaline myopathy 2 | 2019-12-05 | no assertion criteria provided | clinical testing |